Silverarc Capital Management »

Rezolute shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $572k 433k 1.32
2023-06-30 $989k 500k 1.98

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Rezolute

Federated Investors
Vivo Capital
Nantahala Capital Management
Blackstone Group
Vanguard Group
Sphera Funds Management
Citadel Advisors
UBS Group
Rosalind Advisors
BVF
Millennium Management
Charles Schwab Investment Management
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Rezolute